Your browser doesn't support javascript.
loading
Genome-wide mapping of somatic mutation rates uncovers drivers of cancer.
Sherman, Maxwell A; Yaari, Adam U; Priebe, Oliver; Dietlein, Felix; Loh, Po-Ru; Berger, Bonnie.
Afiliação
  • Sherman MA; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Yaari AU; Harvard-MIT Health Sciences and Technology Program, Cambridge, MA, USA.
  • Priebe O; Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Dietlein F; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Loh PR; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Berger B; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Nat Biotechnol ; 40(11): 1634-1643, 2022 11.
Article em En | MEDLINE | ID: mdl-35726091
ABSTRACT
Identification of cancer driver mutations that confer a proliferative advantage is central to understanding cancer; however, searches have often been limited to protein-coding sequences and specific non-coding elements (for example, promoters) because of the challenge of modeling the highly variable somatic mutation rates observed across tumor genomes. Here we present Dig, a method to search for driver elements and mutations anywhere in the genome. We use deep neural networks to map cancer-specific mutation rates genome-wide at kilobase-scale resolution. These estimates are then refined to search for evidence of driver mutations under positive selection throughout the genome by comparing observed to expected mutation counts. We mapped mutation rates for 37 cancer types and applied these maps to identify putative drivers within intronic cryptic splice regions, 5' untranslated regions and infrequently mutated genes. Our high-resolution mutation rate maps, available for web-based exploration, are a resource to enable driver discovery genome-wide.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Taxa de Mutação / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nat Biotechnol Assunto da revista: BIOTECNOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Taxa de Mutação / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nat Biotechnol Assunto da revista: BIOTECNOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos